Now, the biotechnology sector was one of the best performing sectors, especially XBI during the upsurge, was n't it? Strong move, pullback bought, another new all-time high, and recently attempted to form a bullish "cup and handle" pattern as well . He couldn't get there exactly.
XBI — All updates
7 entries loaded; 1 direction changes
Biotechnology has a 50-day moving average in a downward trend. This is a group with potential , you know, it has relative strength. amazing. Amazing. Relative strength means that it does not break down with the market, i.e., it does not fall as much as the rest of the market.
It is cohesive. Well, you don't make profits from simply holding on. You profit from absolute power. Relative strength is good for predicting what might happen next, but it is not a reason to buy.
We have, as I have indicated here, these lower peaks. It appeared to have the potential to turn around if it did something like that, because the 50-day moving average would start to flatten out.
Last week I reviewed this possible scenario and it remains my preferred scenario . It's not a prediction, but I'd like everyone to start talking about this "head and shoulders" pattern .
We break down, maybe test the 200- day moving average, or even break it, then we drop to the year-to-date pivot point, and then we do this. And then , when everyone starts talking about the very obvious head and shoulders pattern, it turns out to be a trap for bears.
We go back up here and then start building for the next upward push by the end of the year. Not a prediction, but definitely my favorite scenario. I love it when we get that failed hack first.
I want to ask you about this XBI. You've always um I feel like had a had a warm spot sort of there, Brian, for some of the biotech names. Uh and you've given us some great, you know, great longs and whatnot in the space as well. But what do you think about XBI right here?
Biotechs also failed to move close to the 50-day moving average. This is what I told subscribers yesterday, that yes, we are seeing some bounce, but our 5-day moving average is still down.
Our 50-day moving average is also trending downward.
I think there could be a nice situation here and you can see I've drawn it , this is one shoulder, this is one head and this is the other shoulder. In fact, it's such a clear pattern that I think what's probably going to happen is it's going to come down , break the neckline here, and then everyone who's read technical analysis books will say, hey, that made a big top. It formed a Head and Shoulders pattern.
A name, or perhaps more of a sector I know you often look at; You have given us a few great individual names. I know you mentioned the ETF, and that is biotech. There are many names here that you have mentioned for swing trades and the like.
You gave us a few . I believe that even CRISPR and that sort of thing are names you have given us. Maybe I'm wrong, but what about the XBI today?
Okay, so this is the XBI on the intermediate term. It has been rising. It has been acting great. Every flag has turned up on the upside here as you can see right here and right there.
But now we are starting to really stall out a little bit versus that 170 area.
97 to about 1019 is when that low is due. What is happening with this overall translation really really strong? This is a right-hand translation where we have used up most of that cycle rallying.
It's it is leaving a short window of time for a pullback after which we would be looking for still new highs uh here as we get out out likely into year end uh in the XBI.
And of course, the big move this week was in the biotech stocks. They look like they're magnetized to the new to a new all-time high up in here. That would bring this XBI up to 175 basically.
Another 10 points higher from you know, 9 points higher from here. And like I said, it seems magnetized to there.